Glutamate and neuropsychiatric disorders : current and emerging treatments / Zoran M. Pavlovic, editor.
Pavlović, Zoran M., editor.
2022
QP364.5 .G58 2022
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Glutamate and neuropsychiatric disorders : current and emerging treatments / Zoran M. Pavlovic, editor.
ISBN 9783030874803 (electronic bk.)
303087480X (electronic bk.)
9783030874797
3030874796
DOI https://doi.org/10.1007/978-3-030-87480-3
Published Cham : Springer, [2022]
Copyright ©2022
Language English
Description 1 online resource : illustrations (chiefly color)
Item Number 10.1007/978-3-030-87480-3 doi
Call Number QP364.5 .G58 2022
Dewey Decimal Classification 612.8
Summary This volume provides a comprehensive overview of recent advances in targeting glutamate signaling for the treatment of major psychiatric and neurological disorders. It draws on the latest findings in glutamate neurobiology and offers valuable insights into the application of translational principles in neuroscience drug discovery and development. In each chapter, glutamate as a neurotransmitter, its receptors and transporters, and their interplay with other neurotransmitters and neurotrophic factors, are discussed in the context of a specific, highly prevalent and disabling CNS disease. Most recent and detailed information is provided on Ischemic Stroke, Chronic Stress, Major Depressive Disorder, Bipolar Disorder, Autism Spectrum Disorders (ASD), Posttraumatic Stress Disorder (PTSD), Alzheimers Dementia, Schizophrenia, Impulsive Aggression, Substance Use Disorders (SUD), Amyotrophic Lateral Sclerosis (ALS), Chronic Pain, Multiple Sclerosis, Parkinsons Disease, Attention Deficit Hyperactivity Disorder (ADHD), Migraine, Epilepsy and Anxiety disorders. Moreover, the book includes an extensive overview of glutamatergic treatments already available on the market, and those which are currently in pharmaceutical drug development pipelines. The primary beneficiaries will be neurology and psychiatry specialists and residents, neuroscientists, neuropharmacologists, pharmaceutical industry and clinical research organization professionals, academics, and clinicians working with psychiatric and neurological patients with comorbidities such as cardiologists, pulmonologists, and endocrinologists. This book will also appeal to psychiatry and neurology subspecialists and clinicians working in neuroscience labs seeking an easy-to-understand yet comprehensive overview of contemporary evidence-based clinical insights backed by basic science (preclinical) research evidence. Given its scope, the book is also a unique and indispensable resource for both preclinical and clinical neuroscientists, medical advisors, and clinical research specialists in the pharmaceutical industry. In addition, it will appeal to neuroscience and neuropsychopharmacology students and guide them through the complexities of glutamate involvement in the pathophysiology of the most common debilitating brain diseases with high unmet medical needs.
Access Note Access limited to authorized users.
Source of Description Online resource; title from PDF title page (SpringerLink, viewed April 13, 2022).
Added Author Pavlović, Zoran M., editor.
Available in Other Form Print version: 9783030874797
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Treatments Against Glutamatergic Excitotoxicity in Ischemic Stroke
Definitions and Concepts of Stress
Role of Glutamatergic Neurotransmission in the Pathophysiology of Stress-Related Disorders and Chronic Stress Response
Current Glutamatergic Treatments and Future Directions for Glutamate-Based Management of Chronic Stress and Stress-Related Disorders
The Role of the Glutamate System in Posttraumatic Stress Disorder and Glutamate-Based Treatments
Glutamate in Migraine Neurobiology and Treatment
Astrocyte Glutamate Transporter EAAT2 in Alzheimer Dementia
The Glutamatergic System as a Target for the Development of New Pharmacological Treatments of Bipolar Disorder
CNS Glutamate in Impulsive Aggression
Glutamatergic Treatments for Parkinsons' Disease
The Modulation of Glutamatergic Signaling as a Potential Therapeutic Strategy for Major Depression
Glutamate-Based Treatment for Amyotrophic Lateral Sclerosis/Motor Neuron Disease
Modulation of Glutamate for Chronic Pain Management
Pharmacological Role of Glutamate Transporters in Substance Use Disorders
Glutamate in Multiple Sclerosis: From Pathophysiology to Treatments
The Role of Glutamate Dysregulation in the Etiology of ADHD
Glutamate, Glutamatergic Drugs and Schizophrenia
Glutamate and Epilepsy: An Insight from Temporal Lobe Epilepsy
Glutamate Function in Anxiety Disorders and OCD: Evidence from Clinical and Translational Studies
Modulators of Glutamatergic Signaling as Potential Treatments for Autism Spectrum Disorders.

Browse Subjects

Show more subjects...

Statistics

from
to
Export